Please don't hesitate to contact us if you have any questions or other inquiries.

Nordic Bioscience is participating in EASD 2022

"EASD holds its Annual Meeting in a different European city each year with more than 15,000 delegates from over 130 countries attending. The scientific programme includes more than 1,200 talks and presentations on the latest results in diabetes research by leading experts in the field. The global diabetes community can benefit from the latest research and innovations in the field of diabetes and offers various options for exchange and interaction." (EASD)

We will be at EASD 2022 to take a deep dive into diabetes research and discuss the latest developments in the field. We are hosting several presentations this year:

 

September 23, 2022

SESSION 37 - OP 37 Insulin deficiencies and cardiovascular disease

10:00 AM - 10:15 AM              

218 - Endotrophin is a risk marker of complications in a type 1 diabetes cohort

A.L. Møller, N.H. Tougaard, P.F. Rønn, T.W. Hansen, F. Genovese, M.A. Karsdal, D.G.K. Rasmussen, P. Rossing

https://www.abstractsonline.com/pp8/#!/10613/presentation/1070

 

September 20, 2022

SESSION B - SO 38 SGLT2 inhibitors and renal outcomes

1:00 PM - 2:00 PM                    

549 - Combination treatment impacts levels of endotrophin in the drug combinations for rewriting trajectories of renal pathologies in type 2 diabetes (DC-Ren) study

F. Genovese, A.L. Møller, S. Thöni, F. Keller, S. Sharifli, D.G.K. Rasmussen, G. Mayer

https://www.abstractsonline.com/pp8/#!/10613/presentation/1230

 

September 20, 2022

SESSION A - SO 73 Diabetes in the vessels

11:45 AM - 12:45 PM               

822 - Endotrophin as a risk marker of complications in a type 2 diabetes cohort

N.H. Tougaard, A.L. Møller, P.F. Rønn, T.W. Hansen, F. Genovese, M.A. Karsdal, D.G.K. Rasmussen, P. Rossing

https://www.abstractsonline.com/pp8/#!/10613/presentation/1219

 

September 21, 2022

SESSION D - SO 58 Autonomic rhythm

1:15 PM - 2:15 PM                    

709 - Collagen turnover is associated with cardiovascular autonomic and peripheral neuropathy in type 1 diabetes: Novel pathophysiological mechanism?

C. Hansen, D.G.K. Rasmussen, T.W. Hansen, S.H. Nielsen, S. Theilade, M.A. Karsdal, F. Genovese, P. Rossing

https://www.abstractsonline.com/pp8/#!/10613/presentation/375

 

 

We hope to see you there!

Please don't hesitate to contact us if you have any questions or other inquiries.

Are you interested in learning more about Nordic Bioscience?
Enter your information in the form and a representative will contact you shortly.

By submitting this form you agree to our terms and conditions.